Mineralys Therapeutics, Inc. MLYS Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s common stock shares outstanding?
- Mineralys Therapeutics, Inc. (MLYS) reported common stock shares outstanding of $146.32M in Q4 2025.
- How has Mineralys Therapeutics, Inc.'s common stock shares outstanding changed year-over-year?
- Mineralys Therapeutics, Inc.'s common stock shares outstanding increased by 1399.8% year-over-year, from $9.76M to $146.32M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s common stock shares outstanding?
- Over 4 years (2021 to 2025), Mineralys Therapeutics, Inc.'s common stock shares outstanding has grown at a 511.0% compound annual growth rate (CAGR), from $105K to $146.32M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.